Thomas Carroll

Dr. Thomas Carroll

Bioinformatics Resource Centre, The Rockefeller University, New York, 10065 NY, USA

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 February 2016 in Journal of Empirical Research on Human Research Ethics
Verified
Journal Article
Closed access
PDF file
JRJill Robinson
Jill Robinson
TCThomas Carroll
Thomas Carroll
LFLindsay Z. Feuerman
Lindsay Z. Feuerman
DPDenise L. Perry
Denise L. Perry
LHLily Hoffman-Andrews
Lily Hoffman-Andrews
FTfor the MedSeq Project Team
for the MedSeq Project Team
An increasing number of individuals are being recruited to whole genome sequencing (WGS) research. When asked hypothetically, the majority of the public express willingness to participate in this type of research, yet little is known about how many individuals will actually consent to research participation or what they perceive the risks to be. The MedSeq Project is a clinical trial exploring WGS in clinical care. We documented primary reason(s) for declining participation and reviewed audio-recorded informed consent sessions to identify participants’ concerns. Of 514 individuals recruited, 173 (34%) actively declined, 205 (40%) enrolled, and the remaining 136 (26%) were ineligible, unresponsive or waitlisted. Although the majority of active decliners cited logistical barriers, 40% cited risks related to the ethical, legal, and social implications (ELSI) of WGS research. Participants similarly discussed ELSI-related concerns but felt the potential benefits of participation outweighed the risks. Findings provide insight into the perspectives of potential WGS research participants and identify potential barriers to participation.

8 November 2021 in JCI Insight
Verified
Journal Article
Open access
PDF file
XHXiaojing Huang
Xiaojing Huang
OMOlivia A. Maguire
Olivia A. Maguire
JWJeanne M. Walker
Jeanne M. Walker
CJCaroline S. Jiang
Caroline S. Jiang
TCThomas Carroll
Thomas Carroll
PCPaul Cohen
Paul Cohen
BACKGROUND: Childhood cancer survivors who received abdominal radiotherapy (RT) or total body irradiation (TBI) are at increased risk for cardiometabolic disease, but the underlying mechanisms are unknown. We hypothesize that RT-induced adipose tissue dysfunction contributes to the development of cardiometabolic disease in the expanding population of childhood cancer survivors. METHODS: We performed clinical metabolic profiling of adult childhood cancer survivors previously exposed to TBI, abdominal RT, or chemotherapy alone, alongside a group of healthy controls. Study participants underwent abdominal s.c. adipose biopsies to obtain tissue for bulk RNA sequencing. Transcriptional signatures were analyzed using pathway and network analyses and cellular deconvolution. RESULTS: Irradiated adipose tissue is characterized by a gene expression signature indicative of a complex macrophage expansion. This signature includes activation of the TREM2 - TYROBP network, a pathway described in diseases of chronic tissue injury. Radiation exposure of adipose is further associated with dysregulated adipokine secretion, specifically a decrease in insulin-sensitizing adiponectin and an increase in insulin resistance–promoting plasminogen activator inhibitor-1. Accordingly, survivors exhibiting these changes have early signs of clinical metabolic derangement, such as increased fasting glucose and hemoglobin A1c. CONCLUSION: Childhood cancer survivors exposed to abdominal RT or TBI during treatment exhibit signs of chronic s.c. adipose tissue dysfunction, manifested as dysregulated adipokine secretion that may negatively impact their systemic metabolic health. FUNDING: This study was supported by Rockefeller University Hospital; National Institute of General Medical Sciences (T32GM007739); National Center for Advancing Translational Sciences (UL1 TR001866); National Cancer Institute (P30CA008748); American Cancer Society (133831-CSDG-19-117-01-CPHPS); American Diabetes Association (1-17-ACE-17); and an anonymous donor (MSKCC).

27 August 2019 in Frontiers in Immunology
Verified
Journal Article
Open access
PDF file
LDLaura M. Davison
Laura M. Davison
JLJessica C. Liu
Jessica C. Liu
LHLei Huang
Lei Huang
TCThomas Carroll
Thomas Carroll
AMAndrew L. Mellor
Andrew L. Mellor
TJTrine N Jørgensen
Trine N Jørgensen
B6.Nba2 mice spontaneously develop a lupus-like disease characterized by elevated levels of serum anti-nuclear autoantibody (ANA) immune complexes and constitutive type I interferon (IFNα) production. During disease progression, both plasmacytoid dendritic cells (pDCs) and antibody secreting plasma cells accumulate in spleens of B6.Nba2 mice. Indoleamine 2,3-dioxygenase (IDO) has been suggested to play a role in several autoimmune diseases including in the MRL/lpr model of mouse lupus-like disease; however, it remains unknown if IDO is involved in disease development and/or progression in other spontaneous models. We show here that IDO1 protein and total IDO enzymatic activity are significantly elevated in lupus-prone B6.Nba2 mice relative to B6 controls. IDO1 expression was restricted to PCs and SignR1+ macrophages in both strains, while significantly increased in B6.Nba2-derived SiglecH+ (SigH+) pDCs. Despite this unique expression pattern, neither pharmacologic inhibition of total IDO nor IDO1 gene ablation altered serum autoantibody levels, splenic immune cell activation pattern, or renal inflammation in B6.Nba2 mice. Interestingly, IDO pharmacologic inhibition, but not IDO1 deficiency, resulted in diminished complement factor C'3 fixation to kidney glomeruli, suggesting a possible therapeutic benefit of IDO inhibition in SLE patients with renal involvement.

1 May 2017 in Journal of Investigative Dermatology
Verified
Journal Article
Closed access
TCThomas Carroll
Thomas Carroll
JWJonathan S. Williams
Jonathan S. Williams
KDKenneth Daily
Kenneth Daily
TRTova Rogers
Tova Rogers
TGTara Gelb
Tara Gelb
IBIsaac Brownell
Isaac Brownell

6 May 2020 in bioRxiv
Verified
Preprint
Open access
PDF file
DMDiego Mourão
Diego Mourão
SCShoudeng Chen
Shoudeng Chen
USUwe Schaefer
Uwe Schaefer
LBLeonia Bozzacco
Leonia Bozzacco
LCLeticia Carneiro
Leticia Carneiro
ATAlexander Tarakhovsky
Alexander Tarakhovsky
The mimicry of host proteins by viruses contributes to their ability to suppress antiviral immunity and hijack host biosynthetic machinery 1 . Host adaptation to evade this exploitation depends on host protein functional redundancy 2 . Non-redundant, essential host proteins have limited potential to adapt without severe consequences 3 . Histones, which are essential for genome architecture and control of gene expression, are among the most evolutionary conserved proteins 4 . Here we show that the capsid protein of the flavivirus yellow fever virus (YFV), mimics histone H4 and interferes with chromatin gene regulation by BRD4, a bromodomain and extraterminal domain (BET) protein. Two acetyl-lysine residues of YFV capsid are embedded in a histone-like motif that interacts with the BRD4 bromodomain, affecting gene expression and influencing YFV replication. These findings reveal histone mimicry as a strategy employed by an RNA virus that replicates in the cytosol 5 and define convergent and distinct molecular determinants for motif recognition of the viral mimic versus histone H4.

13 August 2022 in Entropy
Verified
Journal Article
Open access
PDF file
RHRenee S. Hoekzema
Renee S. Hoekzema
LMLewis Marsh
Lewis Marsh
OSOtto Sumray
Otto Sumray
TCThomas Carroll
Thomas Carroll
XLXin Lu
Xin Lu
HHHeather A. Harrington
Heather A. Harrington
Analysis of single-cell transcriptomics often relies on clustering cells and then performing differential gene expression (DGE) to identify genes that vary between these clusters. These discrete analyses successfully determine cell types and markers; however, continuous variation within and between cell types may not be detected. We propose three topologically motivated mathematical methods for unsupervised feature selection that consider discrete and continuous transcriptional patterns on an equal footing across multiple scales simultaneously. Eigenscores (eigi) rank signals or genes based on their correspondence to low-frequency intrinsic patterning in the data using the spectral decomposition of the Laplacian graph. The multiscale Laplacian score (MLS) is an unsupervised method for locating relevant scales in data and selecting the genes that are coherently expressed at these respective scales. The persistent Rayleigh quotient (PRQ) takes data equipped with a filtration, allowing the separation of genes with different roles in a bifurcation process (e.g., pseudo-time). We demonstrate the utility of these techniques by applying them to published single-cell transcriptomics data sets. The methods validate previously identified genes and detect additional biologically meaningful genes with coherent expression patterns. By studying the interaction between gene signals and the geometry of the underlying space, the three methods give multidimensional rankings of the genes and visualisation of relationships between them.